Navi Medical得到林业发展局对Neonav系统的批准,这是首次使用ECG进行准确的儿科装置定位。 Navi Medical gets FDA approval for Neonav® system, a first for accurate pediatric device placement using ECG.

纳维医疗技术公司已获得FDA批准,用于其Neonav®心电图尖端位置系统,这是一种首创的设备,用于准确地放置儿童患者的中央静脉接入设备. Navi Medical Technologies has received FDA clearance for its Neonav® ECG Tip Location System, a first-of-its-kind device for accurate placement of Central Venous Access Devices in pediatric patients. 利用实时ECG信号,它可以减少安置不当等风险,并可以降低对胸前X光检查的需求,加速护理和减少并发症。 Using real-time ECG signals, it reduces risks like misplacement and can lower the need for chest X-rays, speeding up care and reducing complications. 该公司计划扩大在美国的市场,突出医疗技术的进步。 The company plans to expand in the U.S. market, highlighting medical technology advancements.